Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 163 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1621 6.0 months Advanced hepatocellular carcinoma 3 Biologic therapy
Chemotherapy
Erasme University Hospital Belgium 9/2007
Treatment Details: Patients: This study involved 109 patients with advanced hepatocellular carcinoma. The patients ranged in age from 38 to 84 years. The majority were men, and most cases were caused by eth
 
1622 5.9 months GBM 4 Biologic therapy
Erasmus University Hospital Netherlands 10/2008
Treatment Details: Patients: This phase 2 study involved 112 patients with recurrent gliomas. Fifty-one patients had glioblastoma, 25 had anaplastic astrocytomas, and 36 had anaplastic oligodendroglioma/mixed
 
1623 5.9 months Resistant GBM 5 Biologic therapy
Chemotherapy
Duke University Medical Center United States 3/2009
Treatment Details: Patients: This phase 2 trial involved 66 patients, 44 of whom were male. Of these, 34 patients had glioblastoma multiforme, 28 had anaplastic astrocytoma, and 4 had anaplastic oligodendrog
 
1624 5.9 months Metastatic breast cancer 4 Chemotherapy
The Ottawa Hospital Regional Cancer Centre Canada 7/2009
Treatment Details: Patients: This phase 2 study involved sixteen women with metastatic breast cancer. Their median age was 54, ranging from 33 to77 years of age. Fourteen of these women had previously been t
 
1625 5.9 months Metastatic melanoma 5 Chemotherapy
Addenbrooke’s Hospital United Kingdom 1/2010
Treatment Details: Patients: This study involved 152 patients with metastatic malignant melanoma. The median patient age was 62 years and 54.6% were male. Treatment: Patients were treated with the chemot
 
1626 5.9 months Advanced NSCLC 5 Chemotherapy
Aichi Cancer Center Aichi Hospital Japan 2/2012
Treatment Details: Patients: This phase 2 study involved advanced non-small cell lung cancer patients with no previous chemotherapy who were divided into two separate treatment groups. In group A, there were
 
1627 5.8 months Advanced hepatocellular carcinoma 5 Biologic therapy
Università Cattolica del Sacro Cuore Italy 2/2013
Treatment Details: Patients: This phase 2 study involved 34 advanced hepatocellular carcinoma patients who had not been previously treated. The median patient age was 68 years and 91.2% were male. Treatme
 
1628 5.8 months Advanced hepatocellular carcinoma 5 Biologic therapy
Mayo Clinic United States 8/2012
Treatment Details: Patients: This study involved 28 advanced hepatocellular carcinoma patients with an average age of 69 years; 89.3% were male. Treatment: Patients were treated with the biologic therapy
 
1629 5.8 months Metastatic urothelial carcinoma 5 Biologic therapy
Chemotherapy
Dana-Farber Cancer Institute United States 2/2012
Treatment Details: Patients: This study involved metastatic urothelial cancer patients who had been previously treated with a platinum-based therapy. Patients were divided into two separate treatment groups.
 
1630 5.8 months Recurrent GBM 4 Biologic therapy
Chemotherapy
Duke University Medical Center United States 5/2011
Treatment Details: Patients: This study involved 25 patients with recurrent glioblastoma, who had received prior bevacizumab treatment. The median age of the group was 52 years and 68% were male. Treatmen
 
Page 163 of 187  | Previous Page  | Next Page